In the present review, all ten studies had reported baseline medication status and most CAD patients were using medications for BP control, such as beta-blockers, calcium channel blockers, angiotensin-converting enzyme inhibitors, and nitrates. The gene discussed is ACE; the disease is coronary artery disorder.